
29.11MCAD
Type
Common Stock
Exchange
TO
Currency Code
CAD
Currency Name
Canadian Dollar
Country Name
Canada
Country ISO
CA
ISIN
CA59501P1045
CUSIP
59501P104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
September
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.18
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.04
Wall Street Target Price
0.40
EPS Estimate Current Year
-0.01
EPS Estimate Next Year
0.01
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
14,813,117
Gross Profit TTM
6,294,136
EBITDA
-3,868,267
Profit Margin
-38.62%
Return On Assets TTM
-8.63%
Return On Equity TTM
-20.36%
Revenue Per Share TTM
0.107
Qtly Revenue Growth YOY
-36.60%
Diluted Eps TTM
-0.04
Qtly Earnings Growth YOY
-94.70%
Trailing PE
0.00
Forward PE
17
Price Sales TTM
2.7847
Price Book MRQ
1.6955
Enterprise Value Revenue
2
Enterprise Value EBITDA
65
0.86
4.88%9.64
3.66%1.44
3.24%13.53
1.88%14.50
0.00%0.53
0.00%0.07
-7.14%0.95
-5.00%0.13
-3.85%9.46
-3.47%